Profiles of 24 San Diego-area oncology, immuno-oncology, cell therapy and diagnostics companies, with HQ, lead programme, stage and why each…
In 2027 the big genomics and cancer immunology research meetings fall in the same week. Here are the spatial, single-cell,…
A practical guide to the January partnering week in San Francisco for oncology biotechs, BD teams and their CRO, diagnostics…
Forty biotech and life science conferences in 2027 across the US, Europe and Asia, month by month, with verified dates,…
A themed calendar of the 2027 biomarker, companion diagnostics, molecular pathology, genomics, liquid biopsy and spatial biology conferences in the…
Cell therapy, T cell engagers, cancer vaccines and intratumoural therapy are turning biomarkers into eligibility gates, manufacturing inputs and response…
How the EU IVDR applies to companion diagnostics: class C rules, the mandatory EMA consultation, the current transition deadlines, the…
In vivo CAR-T programmes the patient's own T cells with a single IV dose, removing apheresis and manufacturing. Here is…
How spatial proteomics and spatial transcriptomics compare for immuno-oncology biomarker discovery: platforms, published evidence on checkpoint response, clinical translation hurdles…
A month-by-month calendar of the major oncology, immuno-oncology and biomarker conferences from November 2026 to December 2027, with verified dates,…
300+ senior leaders. Two streams. One agenda: advancing precision oncology.